News

Pfizer to start large study to test COVID-19 vaccine in children below 12

Pfizer to start large study to test COVID-19 vaccine in children below 12
Health
Pfizer Inc said on Tuesday it will start a large study to test its COVID-19 vaccine in children below 12 and selected a dosing regime for the trial.

The study will enroll up to 4,500 children at more than 90 clinical sites in the United States, Finland, Poland and Spain, the company said.

Pfizer s vaccine has been authorized for use in children as young as 12 in Europe, the United States and Canada.

The company said it has selected a dose of 10 micrograms in children between 5 and 11 years of age and 3 micrograms between for infants in age-group of 6 months to five.

Inoculating children and young people is considered a critical step toward reaching "herd immunity" and taming the COVID-19 pandemic.
Read more on CTVnews
News Topics :
Similar Articles :
Science
After a first step study in a small number of young children to test different doses, Pfizer is ready to enroll about 4, 500 young volunteers at more than 90 sites in...
Science
Canada U.K. Australia España France Ελλάδα Greece Italia 日本 Japan 한국 Korea Quebec U.S. Edition Pfizer announced Wednesday that its COVID 19 vaccine is safe and strongly protective in kids as...
World
Pfizer announced Wednesday that its COVID 19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they...
Top Stories
Study subjects who received Moderna s COVID 19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine. If...
Top Stories
Health Canada said Wednesday it was authorizing the use of Pfizer BioNTech’s COVID 19 vaccine for Canadians aged 12 and up. “This is the first COVID 19 vaccine authorized in Canada for use...